HIV Coinfection Clinical Trial
Official title:
A Multicenter, Randomized, Blinded, Placebo-controlled Study To Evaluate The Safety Of Maraviroc In Combination With Other Antiretroviral Agents In Hiv-1-infected Subjects Co-infected With Hepatitis C And/or Hepatitis B Virus
To describe liver enzyme elevations in patients who are coinfected with HIV and either Hepatitis C (HCV) and/or Hepatitis B (HBV) receiving maraviroc or placebo in combination with their current suppressive anti-HIV drug therapy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04568967 -
TB-CAPT EXULTANT - HIV
|
N/A | |
| Not yet recruiting |
NCT05553236 -
Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
|
N/A | |
| Completed |
NCT05323396 -
HIV And Parasitic Infection (HAPI) Study
|
N/A | |
| Recruiting |
NCT05342064 -
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
|
N/A | |
| Completed |
NCT03126370 -
Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)
|
Phase 4 | |
| Active, not recruiting |
NCT04652804 -
Supporting Treatment Outcomes Among PWID
|
N/A | |
| Completed |
NCT05065905 -
Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04708496 -
Optimizing Malaria Treatment for HIV-Malaria Co-infected Individuals
|
Phase 4 | |
| Recruiting |
NCT05965427 -
Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV
|
||
| Recruiting |
NCT04930744 -
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
|
Phase 2 |